Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis
Authors:
- Joan OlivaJoan Oliva
- Samuel W. FrenchSFSamuel W. French
- Jun LiJLJun Li
- Fawzia Bardag-GorceFBFawzia Bardag-Gorce
- 1 August 2012
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 93 (1) , 26-34
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Resveratrol alleviates alcoholic fatty liver in miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- The value of proteasome inhibition in cancerDrug Discovery Today, 2008
- Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposiumThe American Journal of Clinical Nutrition, 2007
- Image-Based Screening for the Identification of Novel Proteasome InhibitorsSLAS Discovery, 2007
- Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding modelJournal of Hepatology, 2006
- Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome ActivityCancer Research, 2006
- Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulumJournal of Gastroenterology and Hepatology, 2006
- Alcohol and lipid metabolismJournal of Gastroenterology and Hepatology, 2006
- Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cellsBlood, 2006
- Metformin Prevents Alcohol-Induced Liver Injury in the Mouse: Critical Role of Plasminogen Activator Inhibitor-1Gastroenterology, 2006